Edition:
India

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

8.92USD
11:20pm IST
Change (% chg)

$-0.33 (-3.57%)
Prev Close
$9.25
Open
$9.12
Day's High
$9.37
Day's Low
$8.78
Volume
15,962
Avg. Vol
47,018
52-wk High
$13.09
52-wk Low
$5.36

Jaeger, Wilfred 

Dr. Wilfred E. Jaeger M.D. serves as Independent Director of the Company. Dr. Jaeger has served as a member of our Board since May 2006. Dr. Jaeger co-founded Three Arch Partners, a healthcare-focused investment firm, in 1993 and served as a Managing Member until December 2019. Prior to co-founding Three Arch Partners, Dr. Jaeger was a general partner at Schroder Ventures. Dr. Jaeger also serves on the board of directors of Neuronetics, Inc. and Nevro Corp., as well as numerous private companies. During the last five years, Dr. Jaeger previously served on the board of directors of Threshold Pharmaceuticals, Inc. Dr. Jaeger received a B.S. in Biology from the University of British Columbia, an M.D. from the University of British Columbia School of Medicine and an M.B.A. from Stanford University. We believe that Dr. Jaeger’s financial and medical knowledge and experience make him a key contributor to our Board.

Basic Compensation

Total Annual Compensation, USD 48,867
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 74,074
Fiscal Year Total, USD 122,941

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

157,592

Roger Tung

2,772,350

Marc Becker

1,887,420

Nancy Stuart

1,908,030

James Cassella

1,695,040

Jeffrey Munsie

--
As Of  31 Dec 2019